Stifel Lays Out 3 Scenarios For Medivation Takeover By: Benzinga via Benzinga May 02, 2016 at 14:49 PM EDT Stifel analyst Thomas Shrader laid out three scenarios for Medivation Inc (NASDAQ: MDVN) takeover after the biopharma company rejected ... Read More >> Related Stocks: Macy's Sanofi-Aventis S.A. ADR